(Ala11, D-Leu15)-Orexin B human
RSGPPGLQGRAQRL-(D-Leu)-QASGNHAAGILTM-amide
Description
Application Data
Description
-
Orexin B is a highly potent and selective OX2 receptor agonist.
Application Data
-
Catalogue number crb1000496 Molecular Weight 898.5 Sequence (one letter code) RSGPPGLQGRAQRL-(D-Leu)-QASGNHAAGILTM-amide
Sequence (three letter code) H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-(D-Leu)-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2
Purity >95% Storage -20°C References Asahi et al., (2003). Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B. Bioorg. Med. Chem. Lett. 13(1) 111. PMID: 12467628
Shahid et al., (2012). Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex. Br. J. Pharmacol. 165(7) 2292. PMID: 21951179
Wang et al., (2018). The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front. Mol. Neurosci. 11. PMID: 30002617
Manufactured in: United Kingdom Orexin B is one of two closely related peptides; the orexins (also known as hypocretins). These small neuropeptides are secreted from orexin-containing neurons, located mainly in the lateral hypothalamus (LH). Orexins function via the binding and activation of two G-protein–coupled receptors (GPCRs); orexin receptor type 1 (OX1) and 2 (OX2).
[Ala(11), D-Leu(15)]orexin-B is a highly potent and selectiveOX2 receptor agonist which can discriminate between the OX1 and OX2 receptors, with a 400-fold selectivity for the OX2 over OX1. [Ala(11), D-Leu(15)]orexin-B is therefore a beneficial tool for addressing the functional roles of OX2.
The L-leucine residue at position 11 of orexin B is important for selectivity to OX2 over OX1. L-Alanine substitution at position 11 and D-leucine substitution at positions 15 maintain the potency of orexin-B to OX2, while significantly reducing the potency for OX1.
Orexins play several vital roles in a range of physiological activities, including: circadian rhythm; feeding behaviour; energy balance; glucose metabolism; neuroendocrine functions; stress-adaptive responses and reward and addiction. Orexins have also been linked to the pathological processes of neurological diseases such as: narcolepsy; depression; ischemic stroke; drug addiction and Alzheimer’s disease.
(Ala11, D-Leu15)-Orexin B human
The role of β-Amyloid Peptides in Alzheimer's Disease
Alzheimer's disease (AD) is a neurodegenerative disease and the most common cause of dementia. AD is characterised by progressive cognitive decline and memory dysfunction. The two major histopathological lesions in AD are senile plaques composed of diverse beta-amyloid (Aβ) peptide aggregates and neurofibrillary tangles composed of tau proteins aggregates. The dysregulation of Aβ production, folding, clearance…